Related Experiment Video
Updated: Sep 10, 2025
Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
Prognostic Factors in Sinonasal Cancers: A Multicenter Pooled Analysis
Milica Stefanovic1, Alberto Hernando-Calvo2, Jesus Brenes Castro3
1Radiation Oncology Department, Institut Català D'oncologia L'hospitalet.
Objectives:
Sinonasal cancers (SNC) are heterogeneous diseases with different clinical behavior. We aimed to identify prognostic factors in non-metastatic (M0)-SNC.
Methods:
Electronic health records from M0-SNC patients treated with definitive surgery ± postoperative radiotherapy or chemoradiotherapy at two tertiary institutions were reviewed. p16 staining was performed in the squamous cell carcinoma (SCC) subset. Multivariable analysis (MVA) calculated the adjusted hazard ratio (aHR) for histology type (SCC as the comparator), T/N categories, and primary treatment modality for the risk of locoregional failure (LRF), distant metastasis (DM), and deaths.
Results:
A total of 376 patients were eligible including 209 (56%) SCC (p16+: 35; p16-/untested: 157), 42 (11%) adenocarcinoma, 35 (9%) sinonasal undifferentiated carcinoma or sinonasal neuroendocrine tumors (SNUC/SNEC), 33 (9%) mucosal melanoma (MM), 30 (8%) esthesioneuroblastoma (ES), and 27 (7%) adenoid cystic carcinoma (ACC). MVA identified MM histology (aHR 2.03, 95% CI 21.23-3.33), older age (aHR 1.02; 95% CI: 1.00-1.03), T3-4 tumor (aHR 5.08, 95% CI 2.77-9.30), and nodal involvement (aHR: 2.15, 95% CI 1.46-3.16) carried higher mortality risk (all p < 0.05); MM (aHR 10.14, 95% CI 4.90-21.01), ACC (aHR 2.97, 95% CI 1.27-6.96), and SNUC/SNEC (aHR 6.80, 95% CI 3.30-14.01) histologies and T3-4 categories (vs. T1-2, HR 4.79, 95% CI 1.53-14.95) had higher DM risk; T3-4 (aHR 2.33, 95% CI 1.37-3.97) and nodal involvement (aHR 1.70, 95% CI 1.11-2.60) conveyed higher LRF risk while SNUC/SNEC histologies had a lower LRF risk (aHR 0.51, 95% CI 0.26-3.33).
Conclusions:
Different SNC histology types exhibit distinct patterns of relapse and survival, highlighting the need for different management strategies.
